They are administered through small subcutaneous injections similar to insulin shots
How GLP-1 Users Are Reshaping Consumer Spending Beyond Food Right now, adoption of weight-loss medications known as GLP-1s has reached a major milestone in the US, with around one in four adults reporting they are using or considering using the drugs
Beneficial for neurodegenerative diseases such as Alzheimers disease and Parkinsons disease
Retrieved from [Accessed October 8, 2024]
Common risks of skipping labs include: Starting treatment in undiagnosed advanced insulin resistance or diabetes Overlooking hepatic dysfunction (e.g., NAFLD) Missing thyroid abnormalities, which may influence weight response Failing to detect renal impairment, which affects drug tolerance In short, GLP-1 therapy is not just a prescriptionit is a metabolic intervention that requires context
There is minimal to no downtime